Evaluating the Effects of an Oral Protein Supplement on Children's Growth Patterns

Completed · Phase 1/Phase 2

Conditions studied: Growth Disorders, Dietary Exposure, Child Development, Bone Development Abnormal, Body Weight, Child Malnutrition

In brief

This single-center, randomized controlled pilot study aims to evaluate the efficacy of TruHeight Growth Protein Shake on improving growth patterns in children aged 4-17 years. Over six months, participants will consume the protein shake daily, five times a week, with outcomes measured in terms of type X collagen concentration in urine, height via a stadiometer, and body composition using an INBODY device.

Key facts

Study ID

NCT06329388

Run by

TruHeight Vitamins

People needed

32

Starts

2023-01-18

Expected to finish

2023-08-11

Last updated by the study team

2024-03-26

Who can join

Age: 4 and older, up to 17. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Children aged 4-17 years old
• At or below the 50th percentile for height according to CDC growth charts
• Able to consume the protein shake
• Willing to maintain their regular diet throughout the study

You may not qualify if…

• Known allergies to ingredients in the protein shake
• Currently receiving growth hormone therapy
• Any medical condition that can affect growth or requires special diet

Where it is running

• SF Research Institute — San Francisco, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.